Empagliflozin trials for Heart failure

All Empagliflozin trials · All Heart failure trials

Phase breakdown

Recruiting trials studying Empagliflozin for Heart failure

• A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
  NCT06024746 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 140 locations
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
  NCT06935370 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 588 locations
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
  NCT06424288 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 652 locations
• Add-on Diuretics in Acute Decompensated Heart Failure
  NCT07372040 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
  NCT06507657 · Phase: Early Phase 1 · Ages: 60 Years and older · Sex: All (male and female) · 1 location
• Feasibility Trial for a Right Ventricular Failure Platform Trial
  NCT06570473 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations

Common questions

How many trials study Empagliflozin for Heart failure?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.